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Abstract-The ototoxicities of eight aminoglycoside antibiotics and fragments were measured 
quantitatively by cochlear perfusion in the guinea pig. Perilymphatic spaces were perfused for 1 hr with 
‘artificial perilymph’ containing 10 mM drug, during which time continuous measurements of cochlear 
microphonic potentials were made. Kanamycin B and neomycin I3 caused the most rapid decline of 
cochlear microphonic potentials, followed by gentamicin Cla = rihostamicin > kanamycin A = G-418. 
Neamine and methylneobiosamine did not show significant effects. The same drugs were tested for 
their interaction with monomolecular films of polyphosphoinositides, and relative binding constants 
were determined. Neomycin B and kanamycin B had the highest affinities to the lipids. followed bv the 
other drugs in the order as seen for toxicity. The correlation between the in situ and in virro ac&s 
of the drugs was r = 0.9. These results support the hypothesis that binding to polyphosphoinositides 
plays an important role in the decrease of the cochlear microphonic potentials. Furthermore, the good 
correlation between the drug actions in the two test systems suggests that an in vitro assay may be 
possible for the assessment of aminoglycoside ototoxicity. 
The interpretation of drug toxicity is frequently com- 
plicated by secondary effects following the initial 
insult. A necessary prerequisite, however, for under- 
standing the molecular mechanism of a drug action 
is the determination of a primary site of action. 
Aminoglycoside antibiotics have nephrotoxic and 
ototoxic properties, and a variety of biochemical 
effects has been reported to result from treatment 
with such drugs. Recently, effects have been shown 
on glycoIysis [l], nucleic acids [2], mucopolysac- 
charides [3] and glucose transport 141. We had pro- 
posed, on the basis of in vivo and in vitro experiments 
[5-S], that the polyphosphoinositides (phosphati- 
dylinositol phosphate and phosphatidylinositol bis- 
phosphate) serve as in viuo receptors for aminog- 
lycosides and render tissues susceptible to these 
drugs. Subsequently, we isolated these lipids by 
affinity chromatography on immobilized neomycin 
[91. 
Interactions between drugs and lipids can be meas- 
ured directly with monomolecular lipid films. Poly- 
phosphoinositides appeared to be unique among var- 
ious anionic phospholipids with respect to both the 
type and the magnitude of the interaction when films 
were challenged with neomycin in the presence of 
Cal+ [lo]. We have proposed that the observed 
increase in surface pressure is indicative of a very 
strong preference of the polyphosphoinositide film 
for neomycin over calcium and other cations. 
In this study we wish to present evidence that such 
an interaction with polyphosphoinositides is a prop- 
erty of ototoxic aminoglycoside antibiotics. We 
determined quantitatively by perilymphatic perfu- 
sion the effect of eight aminoglycosides on cochlear 
microphonic potentials and compared the in sitcc 
action to the ability of the drugs to increase the 
surface pressure of monomolecular films of 
polyphosphoinositides. 
MATERIALS AND METHODS 
Materials. Neomycin sulfate, neamine and neo- 
biosamine were obtained from the Upjohn Co., 
Kalamazoo, MI; kanamycin B and ribostamicin sul-’ 
fate from Charles Pfizer Inc., New York, NY; genta- 
micin Cl8 and antibiotic G-418 from the Schering 
Corp., Nutley, NJ; and kanamycin A from Bristol 
Laboratories, Syracuse, NY. Polyphosphoinositides 
were prepared by chromatography on immobilized 
neomycin [ 111. All water was triple distilled from an 
all-glass still. 
Perilymphatic perfusions. Perilymphatic perfu- 
sions were carried out in male albino guinea pigs 
(~00-250 g). An animal with a positive Preyer hear- 
ing reflex was anesthetized with 1.0-1.4 ml allobar- 
bital/kg body wt (100 mg allobarbital, 400 mg ure- 
thane, 400mg monoethylurea per ml) given 
intraperitoneally. The guinea pig was then placed on 
a heating pad, its body temperature maintained at 
38 ‘_ l”, and artificial respiration provided via tra- 
cheal cannulatjon. Surgical and perfusion techniques 
were essentially similar to those described by Nuttall 
et al. The head of the animal was secured to the head 
holder with clamps fastened into slits made over 
either zygomatic arch. A conventional ventral surg- 
ical approach was used to expose the left auditory 
bulla and cochlea. Two holes were drilled through 
the bony cochlea at the basal turn, and glass capil- 
laries (0.8mm O.D.) were inserted through them, 
one into the Scala vestibuli and the other into the 
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sda tympani, Once the capilhiries were implanted, 
&hey were sealed with Durelon carboxylate cement 
(Espe GmbH, Seefeld, Germany). 
The inlet capillary to the scafa tympani served also 
to hold the electrode for retarding cochlear micro- 
phonic potentials. For the electrode, a S-cm piece 
of stainless steel annealed wire (AWG 36, Cooner 
Sales Co., Chatsworth, CA) was inserted into the 
glass capillary. The excess wire was bent down 
toward the capillary tip, and the other end of the 
capillary was inserted into a 35cm length of poly- 
ethylene tubing (Intramedicat, PE 60). Duco cement 
was used to seal the tubing-capillary junction. The 
outlet capillary was inserted into a 60-cm length of 
polyethylene tubing. Both capillaries and tubing 
were filled with ‘artificial perilymph’ ll2] prior to 
insertion into the cochlea, and flow was started by 
lowering the outlet tubing. 
The perilymphatic spaces were perfused with or 
without drugs at the rate of apQrox~mately 30 @min. 
The perfusate was heated so that the temperature 
of the solution reaching the cochlea was 32-33”. 
Cochlear microphonic potentials were measured in 
response to a sound stimulus of white noise, ranging 
from 20 to 4000 Hz delivered through an ear phone, 
and the sound intensity level was adjusted to give 
a 200-300 FV response. Potentials were read off of 
a digital Data Precision voltmeter, and recorded on 
a Beckman 10 in. recorder. 
~~~oluyer studies. A 250-ml Teflon beaker with 
an inner diameter of 8 cm and a Wilhelmy balance 
were used to measure surface pressure. The subphase 
consisted of 100 ml of 50 m&f sodium 4-(2-hy- 
dropyethyl)-l-piperozine-ethanesulphonic acid 
(HEPES), pH 7.0, and 1 mM Cazt. The ionic 
strength was adjusted to 0.2 with sodium chloride 
previously heated for 12 hr at 700”. The film was a 
mixture of phosphatidylinosit~l phosphate and phos- 
phatidyhnositol b&phosphate in an approximate 1: 2 
molar ratio and was spread as a solution in n-hexane- 
ethano~h~orofo~ (80 : 5 : 15, by vol) . The spread- 
ing solution was added to the subphase so as to 
produce a surface pressure of 20 dynes/cm z!z 10% 
which required approximately 2Opg iipid. A sta- 
tionary 3-m1 syringe whose needle remained in the 
subphase throughout the experiment delivered drugs 
to the solution beneath the film. A Teflon-coated 
magnetic bar stirred the solution at slow speed with- 
out disturbing the film. Drug concentrations in the 
subphase were varied from 10-s to 10U3M. After 
each addition of a drug, the subphase was mixed for 
15 min before surface pressure was measured. Two 
readings each were taken at ten different drug con- 
centrations over the range indicated above. Experi- 
ments were acceptable only if duplicate readings 
agreed within 0.1 dyne/cm; the curves resulting from 
the average values are shown. 
RESULTS 
Ototoxicity. Perilymphatic perfusions could usu- 
ally be carried out for l-2 hr without significant 
detrimental effect on cachfear microphonic poten- 
tials (Fig. I, B, and Table I, controls). There was, 
however, some variability of the stabihty of theprep- 
arations, and a control perfusion of 30 Min preceded 
each testing of a drug. Effects on cochiear micro- 
phonics (Fig. 1, A2) were usually seen within 1.0 min 
(range, 3-17 min) after the introduction of the drug 
into the perfusion fluid [Fig. 1, Al). The decrease 
of the microphonic potential to the end of the linear 
period (Fig. 1, AZ-A3) was considered the measure 
of drug toxicity. This linear period usually Lasted 
15 to 30 min. When no change in slope was apparent 
(e.g. controls and most perfusions with neamine or 
methylneobiosamine), the rate of decrease was cal- 
culated from approximately 10 to 40 min after 
addition of the drug (Fig. 1, B2-B3). All rates, 
Fig. 1. Recording of eachlear microphonic potentials during perilymphatic perfusions. Perilymphatic 
spaces were perfused and microphonic potentials recorded as described in Materials and Methods. 
Perfusions with drugs: Al, addition of drug to artificial perilymph; and A2-A3, initial slope of drug 
action. Control perfusions without drug: Bl, manjpulation of perfusion system corresponding to Al; 
and B2-B3, slope for calculations of loss of microphonic potential (40-X min). 
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Table l.Effects of drugs on cochlear microphonic potentials* 
Loss of cochlear microphonics during perfusion 
Drug 
Rate of loss 
(fiV/min) 





at 30 min 
None 0.22 ? 0.15 0.32 2 0.12 
Methylneobiosamine 0.71 + 0.14 0.91 2 0.30 
Neamine 0.33 2 0.16 0.68 2 0.37 
G-418 0.29 -t 0.23 1.38 2 0.19 
Kanamycin A 0.46 ? 0.18 1.52 t 0.45 
Ribostamicin 0.11 2 0.09 1.83 ? 0.41 
Gentamicin Cta 0.30 2 0.17 2.07 2 0.34 
Neomycin B 0.36 2 0.20 3.56 t 0.68 













24 * 7 
29 ? 6 
51 *6 
47 -e 4 
79 -r- 7 
762 10 
* Perilymphatic spaces were perfused for 30 min with artificial perilymph only (without drug) 
followed by 60 min with the respective drug. Details are described in Materials and Methods. 
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Fig. 2. Effects of aminoglycosides on surface pressure (rr) of polyphosphoinositide films. Increasing 
amounts of a drug were added to the subphase of monomolecular films of polyphosphoinositides as 
described in Materials and Methods. The ratio of phosphatidylinositol phosphate to phosphatidylinositol 
bisphosphate was approximately 8 : 2 in experiment D. Abbreviations: nM, neomycin B; Gm, gentamicin 
Cta; Km A, kanamycin A; Km B, kanamycin B; Rm, ribostamicin; Ne, neamine; Mn, methylneobios- 
amine; and G-418, antibiotic G-418. 
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including those of the preceding control period, were 
calculated by linear regression analysis of the 
described slopes based on readings taken 5 min apart 
(Table 1). 
Calculation of the initial slope may overestimate 
the toxicity of a drug. In a few instances, a steep, 
but brief (5-10 min), initial slope was observed, fol- 
lowed by a more gradual decline of the microphonic 
potential. Therefore, all drug effects were also 
expressed as loss of the cochlear microphonic poten- 
tial within a 30-min p 
i” 
riod after the onset of the 
drug action (Table 1, ast column). 
Both methods yielded essentially similar results. 
Four different levels of toxicity could be distin- 
guished. Kanamy~in B and neomycin B were clearly 
the most ototoxic drugs, gentamicin Crr and ribos- 
tamicin showed an intermediate degree of toxicity, 
while kanamycin A and G-418 displayed low but 
significant effects. Neamine and methylneobiosa- 
mine did not decrease cochlear microphonics sig- 
nificantly during the perfusion time. 
Monolayer studies. All drugs tested above also 
interacted with polyphosphoinositides in the pres- 
ence of 1 mM Ca*+, increasing the surface tension 
of the lipid films (Fig. 2) The responses. however, 
were graded, and the largest increases of surface 
tension were caused bv neomycin B and kanamycin 
B. With these two antibiotics, surface tensions were 
already increased by drug concentrations three 
orders of magnitude lower than the concentration 
of calcium in the experiment. The other drugs had 
lesser but still significant effects, particularly at 
higher concentrations. Antibiotic G-418 was tested 
with a film which contained polyphosphoinositides 
in a ratio different from the other experiments. It 
caused only a small increase in surface pressure but 
neomycin and gentamicin reacted similarly under 
both experimental conditions. 
DISCUSSION 
Cochlear perfusion permits a direct and quanti- 
tative measure of drug toxicity. The concentration 
of the drug in the perilymph and the duration of the 
treatment are under direct experimental control. In 
contrast, conventional assessments of toxicity by sys- 
temic injections are complicated by the rate of 
absorption, renal handling of the drug, serum levels 
and levels in the inner ear fluids. Yet, for a rational 
determination of structure-activity relationships, the 
knowledge of the potential or intrinsic ototoxicity 
of a drug is imperative. 
The drug concentration in the perfusion studies 
was 10.’ M. Drug levels between 10mJ and 1O-3 M can 
be reached in inner ear fluids after repeated systemic 
injection [13, 141. The tissues susceptible to the 
drugs-the organ of Corti and the stria vascularis- 
are surrounded by endolymph, and in periiymphatic 
perfusions the drugs have to reach these tissues by 
diffusion. This may cause dilution of the antibiotic 
and may account for the delay in reaction. The fact 
that toxic and non-toxic drugs are clearly differen- 
tiated at the chosen concentration points to the val- 
idity of the approach. 
While neither the precise origin nor the physio- 
logical role of the cochlear microphonic is known, 
it seems that such measurements are a reliable 
method of assessing the toxicity of aminogly~osides. 
A number of chronic animal studies have demon- 
strated correlations between effects on cochlear 
microphonics and other parameters of ototoxicity, 
e.g. loss of hair cells or whole nerve action potentials 
[El. Although our determination of toxicity rests on 
the effects on the cochlear microphonics alone, the 
results from these acute perfusions are in good agree- 
ment with inferences from chronic studies and find- 
ings of clinical ototoxicity. Neomycin is generally 
considered the most toxic of the antibiotics tested, 
the toxicity of gentamicin is higher than that of 
kanamycin A, and neamine has little or no ototox- 
icity [15,16]. Kanamycin B was reported in one study 
to be considerably more ototoxic than kanamycin A 
1171. 
The ototoxicity of at least one drug, antibiotic G- 
418 [18], does not seem to agree with its systemic 
toxicity. Antibiotic G-418 was highly toxic in pre- 
liminary systemic studies; at 40 mgikgiday, cats 
became ataxic or died after 2-3 days (J. Allan Waitz, 
personal communication). Our perfusions place it 
at a low level of ototoxicity close to kanamycin A. 
Although ribostamicin has been studied for its anti- 
bacteria1 properties [ 191, we are not aware of reports 
of its ototoxicity. This study showed ototoxicity at 
the level of gentamicin Ct;,. 
The salient point of this study is the comparison 
of ototoxicity with drug effects in vitro. A first and 
obvious quantitation of the druglpoly- 
phosphoinositide interaction is the increase in sur- 
face pressure at a given drug concentration, e.g. 
3.2 x 10-“M (Table 2). Lower concentrations pro- 
duce small increases with relatively large variability 
(20.1 dyne/cm), while higher concentrations may 
produce saturation effects (Fig. 2, panel A, 
neomycin). 
The interaction with polyphosphoinositides 
reflects two properties of an antibiotic: (1) its affinity 
to the lipid and ability to displace calcium: and (2) 
the geometry of the molecule which determines the 
magnitude of increase of surface pressure upon dis- 
placement of the small calcium ion. Comparison of 
surface pressures alone lends considerable weight to 
the second point, but in order to calculate affinity 
Table 2, Effects of drugs on monomolecular films of 
polyphosphoinositides 
Displacement 
&rat 32 PM* constant’(f(,,) 
Drug (dynes/cm) (&f) 
Neomycin 12.0 3.9 
Kanamycin B 9.5 6.1 
Ribostamicin 4.0 6.5 
Gentamicin 7.0 6.8 
Kanamycin A 4.5 8.3 
G-418 1.8 8.6 
Neamine 4.0 12.0 
Methylneobiosamine 3.0 12.9 
: A?r from Fig. 2. 
Displacement constants were calculated by Line- 
weaver-Burk analysis (7-70 PM drug). 
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Fig. 3. Scatchard analysis of neomycin interaction with 
polyphosphoinositide films. As described in the text, AT 
is assumed to be a direct function of bound neomycin. The 
term at the ordinate is equivalent to Arr/[free neomycin] 
assuming [total neomycin] >> [bound neomycin]. 
constants, the amount of bound drug has to be meas- 
ured. If we assume that the increase in surface pres- 
sure is a simple function of the amount of drug 
bound, we can treat the data by Scatchard or Line- 
weaver-Burk analysis. Two binding sites of different 
affinity.become evident for neomycin (Fig. 3) and 
the other drugs. This agrees well with our previous 
findings of biphasic neomycin actions on synapto- 
somal membranes and on polyphosphoinositides 
[lo, 201; a ‘calcium-like’ action at lower concentra- 
tions, also seen with other anionic lipids, and a 
noncompetitive action at higher levels of drug, only 
seen with polyphosphoinositides. A Km (or, better 
termed ‘displacement constant’) was calculated for 
all drugs by Lineweaver-Burk analysis from data in 
the concentratior. range, 7-70 ,uM (Table 2). 
The analyses confirm what is apparent from Fig. 
2: toxic aminoglycosides show a larger degree of 
interaction with polyphosphoinositides than the less 
toxic ones. Indeed, the ‘displacement constants’ fol- 
low the ototoxicity very closely; a linear correlation 
between these constants and the loss of cochlear 
microphonics (last column, Table 1) yields a corre- 
lation coefficient of r = 0.93. While the increase in 
surface pressure is not in such good agreement with 
the ototoxicity of some drugs (e.g. G-418 and ribos- 
tamicin), it still provides a differentiation between 
the most toxic and the less toxic compounds. The 
loss of cochlear microphonic correlates with AT, 
r = 0.86. 
While these comparisons of the in sirs and in vitro 
effects already provide a reasonably good correla- 
tion, modifications of the assay systems remain to 
be explored. Lower drug concentrations in the per- 
fusions may yield a better differentiation, e.g. of the 
most toxic drugs, neomycin B and kanamycin B, 
whose toxicities are not significantly different in this 
study (P > 0.4). Another possible modification is the 
composition of the monomolecular films. These were 
a mixture of phosphatidylinositol phosphate and bis- 
phosphate in an approximate molar ratio of 3:7. 
Variations of this ratio clearly influence the magni- 
tude of the increase in surface pressure (compare 
neomycin and gentamicin in Fig. 2, panels A + C vs 
panel D). Moreover, combinations of polyphos- 
phoinositides with other acidic or neutral lipids may 
more closely approximate physiological conditions 
and improve the differentiation between the various 
drugs. 
In any case, the present results strongly support 
our hypothesis that polyphosphoinositides are cru- 
ciallyinvolved in the ototoxicity 17, 211 and, possibly, 
nephrotoxicity (61 of aminoglycoside antibiotics. 
Moreover, they point to the possibility of establishing 
an in vitro system for the determination of amino- 
glycoside toxicity. 
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